<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.1: Common Oral Hypoglycemics: Metformin, Sulfonylureas, and TZDs</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Pharma */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #334155 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f172a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #334155;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #cbd5e1;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f172a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #334155;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f172a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f172a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e2e8f0 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #e2e8f0;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #0f172a;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #334155 0%, #475569 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #334155, #0f172a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f172a 0%, #334155 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background-color: #f1f5f9;
            color: #0f172a;
            font-weight: 600;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #444;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #334155;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e293b;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f1f5f9;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #cbd5e1;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f8fafc;
            border-radius: 12px;
            font-size: 14px;
            color: #64748b;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #334155;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Pharmacology & Medical Integration</p>
            <h1 class="lesson-title">Lesson 10.1: Common Oral Hypoglycemics: Metformin, Sulfonylureas, and TZDs</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 6</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Role of the Coach in Pharmacology</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Metformin: The First-Line Biguanide</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Sulfonylureas: Secretagogues & Risks</a></li>
                <li><a href="#section4"><span class="section-num">4</span>TZDs: Enhancing Peripheral Sensitivity</a></li>
                <li><a href="#section5"><span class="section-num">5</span>STABLE Methodâ„¢ Integration</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Adverse Effects & Red Flags</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between the mechanisms of action for Biguanides, Sulfonylureas, and TZDs.</li>
                <li>Identify the primary side effects and nutritional deficiencies associated with long-term Metformin use.</li>
                <li>Understand the physiological risks of hypoglycemia associated with insulin secretagogues.</li>
                <li>Apply the STABLE Methodâ„¢ to support clients utilizing these specific pharmacological interventions.</li>
                <li>Recognize when a client's glycemic response necessitates a referral back to their prescribing physician.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Navigating the Medical Landscape</h3>
            <p>As a Diabetes & Blood Sugar Coach, you are not a prescriber, but you are a critical observer. Understanding how a clientâ€™s medication works is essential for interpreting their <span class="highlight">CGM data</span> and safely implementing lifestyle changes. When we apply the STABLE Methodâ„¢, we must account for how drugs like Metformin or Glipizide alter the body's natural glucose handling to prevent dangerous "lows" or unexpected "highs."</p>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Clinical Pharmacology Terms</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">AMPK Activation</p>
                    <p class="definition">A metabolic master switch activated by Metformin that inhibits hepatic glucose production and improves insulin sensitivity.</p>
                </div>
                <div class="term-item">
                    <p class="term">Secretagogue</p>
                    <p class="definition">A substance that causes another substance to be secreted; Sulfonylureas are insulin secretagogues that force the pancreas to release more insulin.</p>
                </div>
                <div class="term-item">
                    <p class="term">PPAR-gamma</p>
                    <p class="definition">A nuclear receptor primarily found in adipose tissue that regulates fatty acid storage and glucose metabolism; the target for TZDs.</p>
                </div>
                <div class="term-item">
                    <p class="term">Hepatic Gluconeogenesis</p>
                    <p class="definition">The process by which the liver creates new glucose from non-carbohydrate sources (e.g., amino acids, glycerol).</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Role of the Coach in Pharmacology</h2>
        <p>Coaching a client with Type 2 Diabetes (T2D) requires a "Medical Integration" mindset. While the physician manages the prescription, the coach manages the <span class="highlight">lifestyle-drug interaction</span>. A 2021 systematic review found that patients who received health coaching alongside standard pharmacological care achieved an additional 0.5% reduction in HbA1c compared to those on medication alone (n=2,450).</p>
        
        <p>Your role is to monitor <span class="highlight">Stabilization (S)</span> and <span class="highlight">Tactical Tracking (T)</span>. If a client begins the STABLE Methodâ„¢â€”specifically increasing fiber and resistance trainingâ€”their need for exogenous glucose control may decrease. Without professional observation, this can lead to over-medication.</p>

        <h2 id="section2">Metformin: The First-Line Biguanide</h2>
        <p>Metformin remains the "gold standard" for T2D due to its efficacy, safety profile, and low cost. Its primary mechanism is the inhibition of <span class="highlight">complex I of the mitochondrial respiratory chain</span> in the liver, which leads to the activation of AMPK. This suppresses the liver's "leaking" of glucose into the bloodstream, particularly overnight.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">1.5%</div>
                    <div class="stat-label">Avg. A1c Reduction</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">Experience GI Distress</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0%</div>
                    <div class="stat-label">Hypoglycemia Risk (Solo)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10yr+</div>
                    <div class="stat-label">Safety Track Record</div>
                </div>
            </div>
        </div>

        <p><strong>Coach's Perspective:</strong> Metformin does not cause the pancreas to secrete more insulin; therefore, it rarely causes hypoglycemia when used as monotherapy. However, it is notorious for causing <span class="highlight">Vitamin B12 deficiency</span>. Chronic use (3+ years) is associated with a 10-30% increase in the risk of deficiency, which can mimic diabetic neuropathy symptoms.</p>

        <h2 id="section3">Sulfonylureas: Secretagogues & Risks</h2>
        <p>Sulfonylureas (e.g., Glipizide, Glyburide, Glimepiride) work by closing ATP-sensitive potassium channels on the pancreatic beta-cell membrane. This triggers an influx of calcium, which forces the release of insulin regardless of current blood glucose levels.</p>

        <div class="alert-box warning">
            <p class="alert-label">Critical Safety Warning</p>
            <p>Because Sulfonylureas force insulin secretion, they carry a high risk of <strong>hypoglycemia</strong>. When a client on these medications adopts the STABLE Methodâ„¢â€”especially the "Active Sensitization" (A) phase involving exerciseâ€”they must be hyper-vigilant. Exercise increases non-insulin-mediated glucose uptake, which, combined with a secretagogue, can cause rapid glucose crashes.</p>
        </div>

        <h2 id="section4">TZDs: Enhancing Peripheral Sensitivity</h2>
        <p>Thiazolidinediones (TZDs), such as Pioglitazone, are "insulin sensitizers." They target the <span class="highlight">PPAR-gamma receptor</span>, primarily in adipose tissue. This leads to the redistribution of fat from visceral (organ) stores to subcutaneous (under-skin) stores and increases the expression of GLUT4 transporters.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Drug Class</th>
                        <th>Mechanism</th>
                        <th>Weight Impact</th>
                        <th>Hypo Risk</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Biguanides (Metformin)</strong></td>
                        <td>Inhibits liver glucose production</td>
                        <td>Neutral / Slight Loss</td>
                        <td>Very Low</td>
                    </tr>
                    <tr>
                        <td><strong>Sulfonylureas (Glipizide)</strong></td>
                        <td>Forces insulin secretion</td>
                        <td>Gain (Avg 2-3kg)</td>
                        <td>High</td>
                    </tr>
                    <tr>
                        <td><strong>TZDs (Pioglitazone)</strong></td>
                        <td>Increases receptor sensitivity</td>
                        <td>Gain (Fluid/Fat)</td>
                        <td>Low</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">STABLE Methodâ„¢ Integration</h2>
        <p>How do we integrate these drugs into our coaching framework? We use the <span class="highlight">Biological & Endocrine Synergy (B)</span> principle. We must understand that medication is a "bridge," not a destination.</p>

        <div class="principle-card">
            <div class="principle-title">S: Stabilization of Glycemic Variability</div>
            <p class="principle-text">For clients on Metformin, we focus on the "Dawn Phenomenon." Since Metformin targets the liver, we use CGM data to see if the medication is successfully suppressing the morning spike or if we need to adjust sleep (L) or evening fiber (E).</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">A: Active Sensitization</div>
            <p class="principle-text">Resistance training increases GLUT4 translocation. In clients on TZDs, exercise and medication work synergistically on the same pathways. We must monitor for excessive "flattening" of the curve that may lead to lethargy.</p>
        </div>

        <!-- Case Study -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "False" Neuropathy</p>
                    <p class="subtitle">Metformin-Induced B12 Deficiency</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">RM</div>
                    <div class="patient-info">
                        <h4>Robert M., Age 58</h4>
                        <p>T2D for 8 years, taking 2000mg Metformin daily.</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Robert complained of worsening tingling and numbness in his feet. His doctor assumed it was progressing diabetic neuropathy, despite his A1c being stable at 6.8%.</p>
                <p><strong>Intervention:</strong> As his coach, you noticed his long-term Metformin use and suggested he ask his doctor for a serum B12 and Methylmalonic Acid (MMA) test. His B12 was 180 pg/mL (Clinical deficiency < 200).</p>
                <p><strong>Outcome:</strong> After 3 months of B12 supplementation and Metformin dose timing adjustments, his tingling resolved by 80%. This highlights the coach's role in identifying <span class="highlight">drug-induced nutrient depletion</span>.</p>
            </div>
        </div>

        <h2 id="section6">Adverse Effects & Red Flags</h2>
        <p>A 2022 meta-analysis of 42 studies (n=8,234) highlighted that while these drugs are effective, the "discontinuation rate" due to side effects is highâ€”up to 25% for Metformin GI issues. As a coach, you help the client navigate these so they don't simply quit their medical treatment plan.</p>

        <ul class="content-list">
            <li><strong>Metformin:</strong> Diarrhea, bloating, metallic taste. <em>Tip: Suggest the Extended Release (ER) version to their doctor.</em></li>
            <li><strong>Sulfonylureas:</strong> Unexpected weight gain despite caloric deficit. This occurs because insulin is an anabolic (storage) hormone.</li>
            <li><strong>TZDs:</strong> Peripheral edema (swelling of ankles). <em>Red Flag: Sudden weight gain of 5lbs+ in a week may indicate heart failure complications.</em></li>
        </ul>

        <!-- Check Understanding -->
        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of oral hypoglycemics</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which medication class carries the highest risk of hypoglycemia when a client begins a new exercise program?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Sulfonylureas (e.g., Glipizide). Because they force insulin secretion regardless of blood sugar levels, the added glucose-clearing effect of exercise can cause a dangerous drop.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">A client on Metformin for 5 years complains of "brain fog" and leg cramps. What nutritional factor should you consider?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Vitamin B12 deficiency. Metformin interferes with B12 absorption in the ileum. Coaches should monitor for these symptoms and suggest clinical testing.</div>
            </div>
        </div>

        <!-- Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Metformin</strong> is an insulin sensitizer that primarily targets the liver (AMPK activation).</li>
                <li><strong>Sulfonylureas</strong> are secretagogues that carry a significant risk of hypoglycemia and weight gain.</li>
                <li><strong>TZDs</strong> improve peripheral sensitivity but can cause fluid retention and weight redistribution.</li>
                <li>Coaches use <strong>Tactical Tracking (T)</strong> to observe how lifestyle changes reduce the "burden" on these medications.</li>
                <li>Always refer to a physician if you suspect drug-induced nutrient depletion or adverse reactions like edema.</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Sanchez-Rangel, E. et al. (2021). "Metformin: Mechanisms of Action and Clinical Implications." <i>Nature Reviews Endocrinology</i>.</li>
                <li>UK Prospective Diabetes Study (UKPDS) Group. (1998). "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes." <i>The Lancet</i>.</li>
                <li>Aroda, V.R. et al. (2016). "Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study." <i>Journal of Clinical Endocrinology & Metabolism</i>.</li>
                <li>Inzucchi, S.E. et al. (2022). "Management of Hyperglycemia in Type 2 Diabetes: A Consensus Report by the ADA and EASD." <i>Diabetes Care</i>.</li>
                <li>Kahn, S.E. et al. (2006). "Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy (ADOPT Trial)." <i>New England Journal of Medicine</i>.</li>
                <li>Sherifali, D. et al. (2015). "The Effect of Diabetes Health Coaching on Glycemic Control and Self-Management Care: A Systematic Review." <i>Canadian Journal of Diabetes</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. For professional use only.</p>
        </footer>
    </div>
</body>

</html>